First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Mitchell is now offering simplified implementation options for its ClaimIQ liability a
SAN DIEGO, CA—Mitchell International, a leading provider of technology, connectivity and in
December 2019 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Executive Vice-President, ADESA Analytica
The quarterly LOR summary is produced by
Electric Vehicle (EV) sales did not continue the fast-paced growth seen in 2018 with the release of Tesla’s Model 3, but expert and consumer sentim